June 2024
1. BERTRAND G, Danger Y, Verite F, Sarpentier Guibourg M, et al
   A new platelet alloantigen (Efs(2a)) on glycoprotein GPIIIa leading to neonatal alloimmune thrombocytopenia.
   Transfusion. 2024 Jun 25. doi: 10.1111/trf.17933.
   

   >> Share

   
   
2. GILMORE LE, Chou ST, Ghavam S, Thom CS, et al
   Consensus transfusion guidelines for a large neonatal intensive care network.
   Transfusion. 2024 Jun 17. doi: 10.1111/trf.17914.
   

   >> Share

   
   May 2024
3. 
   Correction to Comparison of Automated Solid Phase vs Manual Saline Indirect Antiglobulin Test Methodology for non-ABO Antibody Titration: Implications for Perinatal Antibody Monitoring.
   Transfusion. 2024 May 8. doi: 10.1111/trf.17866.
   

   >> Share

   
   
4. PETERMANN R, Bianchi F, Saib L, Ferre N, et al
   Severe neonatal thrombocytopenia due to anti-HPA-4b alloantibodies: Third report described in a Caucasian mother.
   Transfusion. 2024 May 1. doi: 10.1111/trf.17863.
   

   >> Share

   
   
5. SHERWOOD MR, Clayton S, Leeper CM, Yazer M, et al
   Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
   Transfusion. 2024;64 Suppl 2:S100-S110.
   

   >> Share

   
   
6. MALONE JR
   Ethical considerations in the use of RhD-positive blood products in trauma.
   Transfusion. 2024;64 Suppl 2:S4-S10.
   

   >> Share

   
   
7. SUSILA S, Ilmakunnas M, Lauronen J, Vuorinen P, et al
   Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland.
   Transfusion. 2024;64 Suppl 2:S119-S125.
   

   >> Share

   
   
8. OOSTERHOFF JJ, Linty F, Visser R, de Vos T, et al
   Generation of human antibodies targeting human platelet antigen (HPA)-1a.
   Transfusion. 2024;64:893-905.
   

   >> Share

   
   April 2024
9. WILSON B, Davison CL, Lopez GH, Millard GM, et al
   A cold case of hemolytic disease of the fetus and newborn resolved by genomic sequencing and population studies to define a new antigen in the Rh system.
   Transfusion. 2024 Apr 30. doi: 10.1111/trf.17205.
   

   >> Share

   
   
10. HEEGER LE, Houben NAM, Caram-Deelder C, Fustolo-Gunnink SF, et al
    Impact of restrictive platelet transfusion strategies on transfusion rates: A cohort study in very preterm infants.
    Transfusion. 2024 Apr 25. doi: 10.1111/trf.17844.
    

    >> Share

    
    February 2024
11. VAAJALA M, Kuitunen I, Mattila VM, Yazer MH, et al
    Effect of major trauma on the expected number of births in Finnish women: A nationwide population-based public data and register analysis.
    Transfusion. 2024 Feb 1. doi: 10.1111/trf.17709.
    

    >> Share

    
    December 2023
12. LONGACRE M, Bendapudi PK
    Fatal hemolytic disease of the newborn due to anti-B Isohemagglutinin: An unfamiliar presentation of a familiar disease.
    Transfusion. 2023 Dec 8. doi: 10.1111/trf.17614.
    

    >> Share

    
    
13. HERNANDEZ MM, Buckley A, Mills A, Meislin R, et al
    Multidisciplinary management of a pregnancy complicated by Glanzmann thrombasthenia: A case report.
    Transfusion. 2023;63:2384-2391.
    

    >> Share

    
    
14. CROWE EP, Hasan R, Saifee NH, Bakhtary S, et al
    How do we perform intrauterine transfusions?
    Transfusion. 2023;63:2214-2224.
    

    >> Share

    
    November 2023
15. NIU S, Vetsch M, Beaudin L, Bodnar M, et al
    Comparison of automated solid phase versus manual saline indirect antiglobulin test methodology for non-ABO antibody titration: Implications for perinatal antibody monitoring.
    Transfusion. 2023 Nov 3. doi: 10.1111/trf.17571.
    

    >> Share

    
    September 2023
16. ABELS E, Jacobs JW, Prior D, Willets LC, et al
    Passive transfer of alloantibodies through breast milk as a mediator of hemolytic anemia.
    Transfusion. 2023 Sep 14. doi: 10.1111/trf.17548.
    

    >> Share

    
    June 2023
17. DESIMONE RA, Plimier C, Goel R, Hendrickson JE, et al
    Associations of donor, component, and recipient factors on hemoglobin increments following red blood cell transfusion in very low birth weight infants.
    Transfusion. 2023 Jun 30. doi: 10.1111/trf.17468.
    

    >> Share

    
    May 2023
18. BAHR TM, Christensen TR, Tweddell SM, Henry E, et al
    Associations between blood donor sex and age, and outcomes of transfused newborn infants.
    Transfusion. 2023 May 22. doi: 10.1111/trf.17417.
    

    >> Share

    
    April 2023
19. ANDREWS J, Josephson CD, Young P, Spinella PC, et al
    Weighing the risk of hemolytic disease of the newborn versus the benefits of using of RhD-positive blood products in trauma.
    Transfusion. 2023 Apr 18. doi: 10.1111/trf.17352.
    

    >> Share

    
    
20. COLVIN ZA, Schiller J, Tsaih SW, Sharma R, et al
    HLA antibodies in fetal and neonatal alloimmune thrombocytopenia.
    Transfusion. 2023 Apr 10. doi: 10.1111/trf.17342.
    

    >> Share

    
    February 2023
21. LU W, Ziman A, Yan MTS, Waters A, et al
    Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study.
    Transfusion. 2023 Feb 23. doi: 10.1111/trf.17276.
    

    >> Share

    
    
22. GHESQUIERE L, Leroy J, Deken V, Tournier A, et al
    Anti-RH1 alloimmunization: At what maternal antibody threshold is there a risk of severe fetal anemia?
    Transfusion. 2023 Feb 3. doi: 10.1111/trf.17264.
    

    >> Share

    
    
23. HE Y, Gao W, Li Y, Xu C, et al
    A single-center, retrospective analysis of 17 cases of hemolytic disease of the fetus and newborn caused by anti-M antibodies.
    Transfusion. 2023 Feb 2. doi: 10.1111/trf.17249.
    

    >> Share

    
    
24. TRAN A, Yan MTS, Branch DR, Blacquiere M, et al
    Severe fetal anemia caused by anti-Jr(a) : Burst forming unit-erythroid colony formation inhibition assay suggesting possible erythroid suppression mechanism.
    Transfusion. 2023 Feb 2. doi: 10.1111/trf.17265.
    

    >> Share

    
    
25. BADAWI MA, Al-Wassia H
    Incompatible red blood cell transfusion for hemolytic disease of the fetus and newborn secondary to anti-U: A case report.
    Transfusion. 2023;63 Suppl 1:S28-S32.
    

    >> Share

    
    January 2023
26. KURODA Y, Miyazaki T, Tsuno NH, Inoue H, et al
    Sim, a new human platelet antigen located on glycoprotein IIIa, identified in a case of fetal-neonatal alloimmune thrombocytopenia in Japan.
    Transfusion. 2023 Jan 20. doi: 10.1111/trf.17255.
    

    >> Share

    
    
27. NING S, Morin PA, Elahie A, Li N, et al
    KEL1 negative red cell transfusions for females of current or future child-bearing potential: A clinical impact and feasibility study.
    Transfusion. 2023;63:59-68.
    

    >> Share

    
    November 2022
28. O'BRIEN KL, Shainker SA, Callum J, Chmait RH, et al
    Primum, non nocere: Whole blood, prehospital transfusion and anti-D hemolytic disease of the fetus and newborn.
    Transfusion. 2022 Nov 30. doi: 10.1111/trf.17209.
    

    >> Share

    
    
29. ZABEIDA A, Chartrand L, Lacroix J, Villeneuve A, et al
    Platelet transfusion practice pattern before and after implementation of a local restrictive transfusion protocol in a neonatal intensive care unit.
    Transfusion. 2022 Nov 12. doi: 10.1111/trf.17184.
    

    >> Share

    
    
30. MAISONNEUVE E, Sohier Lepine M, Maurice P, Pissard S, et al
    Prenatal management of fetal anemia due to pyruvate kinase deficiency: A case report.
    Transfusion. 2022 Nov 8. doi: 10.1111/trf.17177.
    

    >> Share

    
    
31. JANSEN SJ, Ree IMC, Broer L, de Winter D, et al
    Neonatal sepsis in alloimmune hemolytic disease of the fetus and newborn: A retrospective cohort study of 260 neonates.
    Transfusion. 2022 Nov 5. doi: 10.1111/trf.17176.
    

    >> Share

    
    October 2022
32. MATUSIAK K, Patriquin CJ, Deniz S, Dzaja N, et al
    Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia.
    Transfusion. 2022 Oct 14. doi: 10.1111/trf.17144.
    

    >> Share

    
    September 2022
33. GANCAR JL, Shields MC, Wise L, Waller JL, et al
    Red blood cell volume, but not platelet or plasma volume is associated with mortality in neonatal ECMO.
    Transfusion. 2022 Sep 5. doi: 10.1111/trf.17097.
    

    >> Share

    
    
34. LOPEZ GH, Emthip M, Suwanwootichai P, Millard GM, et al
    Hemolytic disease of the fetus and newborn caused by anti-s(D) antibody in a GP.Mur/Mur Thai mother and review of the prevalence of s(D) in Thai blood donors.
    Transfusion. 2022 Sep 5. doi: 10.1111/trf.17086.
    

    >> Share

    
    August 2022
35. KHAYAT CD, Lohade S, Zekavat OR, Kruzhkova I, et al
    Efficacy and safety of fibrinogen concentrate for perioperative prophylaxis of bleeding in adult, adolescent, and pediatric patients with congenital fibrinogen deficiency: FORMA-02 and FORMA-04 clinical trials.
    Transfusion. 2022 Aug 6. doi: 10.1111/trf.17029.
    

    >> Share

    
    July 2022
36. CARR NR, Hulse WL, Bahr TM, Davidson JM, et al
    First report of transfusing low-titer cold-stored type O whole blood to an extremely-low-birth-weight neonate after acute blood loss.
    Transfusion. 2022 Jul 25. doi: 10.1111/trf.17034.
    

    >> Share

    
    
37. OLAFSON C, William N, Howell A, Beaudin L, et al
    Preparing small-dose red cell concentrates (RCCs) for neonatal and pediatric transfusions: Impact of RCC volume, storage, and irradiation.
    Transfusion. 2022 Jul 23. doi: 10.1111/trf.17027.
    

    >> Share

    
    June 2022
38. ARBELL D, Barshtein G, Gural A, Eventov-Friedman S, et al
    Plasma transfusion to premature newborns as a risk factor of necrotizing enterocolitis development: Proposed mechanism.
    Transfusion. 2022;62:1310-1311.
    

    >> Share

    
    May 2022
39. DAVENPORT P, Fan HH, Nolton E, Feldman HA, et al
    Platelet transfusions in a murine model of neonatal polymicrobial sepsis: Divergent effects on inflammation and mortality.
    Transfusion. 2022 May 6. doi: 10.1111/trf.16895.
    

    >> Share

    
    
40. BLOMME S, Nollet F, Rosseel W, Bogaard N, et al
    Routine noninvasive prenatal screening for fetal Rh D in maternal plasma-A 2-year experience from a single center in Belgium.
    Transfusion. 2022;62:1103-1109.
    

    >> Share

    
    
41. KUROISHI A, Takihara Y, Hirayama F
    Current understanding and future perspectives for anti-human platelet antigen-15 antibodies in patients with alloimmune thrombocytopenia: History, laboratory testing, and clinical impact.
    Transfusion. 2022;62:1128-1141.
    

    >> Share

    
    March 2022
42. ARORA S, Dua S, Goel R
    Neonatal and pediatric transfusion practices and policies in India: A survey-based cross-sectional assessment of blood centers.
    Transfusion. 2022 Mar 31. doi: 10.1111/trf.16857.
    

    >> Share

    
    February 2022
43. MAHESHWARI A, Gupta S, Bajpai M
    Ichthyosis in blood donors.
    Transfusion. 2022;62:265-266.
    

    >> Share

    
    
44. ORZINSKA A, Kluska A, Balabas A, Piatkowska M, et al
    Prediction of fetal blood group antigens from maternal plasma using Ion AmpliSeq HD technology.
    Transfusion. 2022;62:458-468.
    

    >> Share

    
    January 2022
45. KRIGSTEIN M, Cromer N
    Navigating the challenges of Bombay phenotype (Oh ) and twin pregnancy; a case report and literature review.
    Transfusion. 2022;62:247-251.
    

    >> Share

    
    
46. CARR NR, Henry E, Bahr TM, Ohls RK, et al
    Fetomaternal hemorrhage: Evidence from a multihospital healthcare system that up to 40% of severe cases are missed.
    Transfusion. 2022;62:60-70.
    

    >> Share

    
    November 2021
47. PARVIZIAN MK, Barty R, Heddle NM, Li N, et al
    Necrotizing enterocolitis and mortality after transfusion of ABO non-identical blood.
    Transfusion. 2021;61:3094-3103.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share